Phase 3 Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose
Clinical trial NCT05567471 · COMPLETED
Trial details
- NCT number
- NCT05567471
- Sponsor
- Bharat Biotech International Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-02-26
- Primary completion
- 2022-05-03
- Enrollment
- 875
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.